These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6129344)

  • 21. Serum gamma-glutamyl transpeptidase, D-glucaric acid excretion and plasma half-life of antipyrine in newborns with severe jaundice of unknown etiology and due to glucose-6-phosphate dehydrogenase deficiency in Greece.
    Malaka-Zafiriu K; Koliouskas D; Kontopoulos E; Danielides B; Cassimos C
    Helv Paediatr Acta; 1981; 36(2):149-58. PubMed ID: 6114077
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of aldosterone in patients with Addison's disease: effect of rifampicin treatment on glucocorticoid and mineralocorticoid metabolism.
    Schulte HM; Mönig H; Benker G; Pagel H; Reinwein D; Ohnhaus EE
    Clin Endocrinol (Oxf); 1987 Dec; 27(6):655-62. PubMed ID: 3455371
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antipyrine metabolism and liver function in patients treated with high-dose medroxyprogesterone.
    Rautio A; Kauppila AJ; Tuimala RJ; Sotaniemi EA
    Biomedicine; 1979 Sep; 31(5):135-8. PubMed ID: 508896
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of nifedipine on hepatic drug oxidation.
    Dickinson TH; Egan JM; Abernethy DR
    Pharmacology; 1988; 36(6):405-10. PubMed ID: 3420161
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The interaction of cigarette smoking and chronic drug ingestion on human drug metabolism.
    Cooksley WG; Farrell GC; Cash GA; Powell LW
    Clin Exp Pharmacol Physiol; 1979; 6(5):527-33. PubMed ID: 498592
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of rifampicin on drug metabolism: differences between hexobarbital and antipyrine.
    Breimer DD; Zilly W; Richter E
    Clin Pharmacol Ther; 1977 Apr; 21(4):470-81. PubMed ID: 849678
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A non-invasive method for the study of hepatic drug metabolism in rodents: antineoplastic drug effects on antipyrine metabolism in mice.
    Wilson VL; Larson RE; Moldowan MJ
    Chem Biol Interact; 1982 Jun; 40(2):159-68. PubMed ID: 7083391
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of rifampicin treatment on the kinetics of mexiletine.
    Pentikäinen PJ; Koivula IH; Hiltunen HA
    Eur J Clin Pharmacol; 1982; 23(3):261-6. PubMed ID: 6129140
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma levels of sulfinpyrazone and of two of its metabolites after a single dose and during the steady state.
    Rosenkranz B; Fischer C; Jakobsen P; Kirstein Pedersen A; Frölich JC
    Eur J Clin Pharmacol; 1983; 24(2):231-5. PubMed ID: 6840173
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [In vivo activity of drug-metabolizing enzymes in various pathological conditions].
    Krakovskiĭ ME; Ashirmetov AKh
    Vopr Med Khim; 1985; 31(1):76-9. PubMed ID: 3984279
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liver blood flow and enzyme induction in man.
    Ohnhaus EE; Noelpp UB; Ramos MR
    Hepatogastroenterology; 1985 Apr; 32(2):61-4. PubMed ID: 4007764
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of chloroquine and primaquine on antipyrine metabolism.
    Back DJ; Purba HS; Park BK; Ward SA; Orme ML
    Br J Clin Pharmacol; 1983 Nov; 16(5):497-502. PubMed ID: 6639836
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interindividual differences in rates of drug oxidation in man.
    Davies DS; Thorgeirsson SS; Breckenridge A; Orme M
    Drug Metab Dispos; 1973; 1(1):411-7. PubMed ID: 4149412
    [No Abstract]   [Full Text] [Related]  

  • 34. The effect of antipyrine and rifampin on the metabolism of diazepam.
    Ohnhaus EE; Brockmeyer N; Dylewicz P; Habicht H
    Clin Pharmacol Ther; 1987 Aug; 42(2):148-56. PubMed ID: 3608348
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of antipyrine and phenobarbital on renal gamma-glutamyltransferase excretion in human urine.
    Wensing G; Neumann U; Ohnhaus EE; Heidemann HT
    Clin Pharmacol Ther; 1990 Nov; 48(5):575-81. PubMed ID: 1977543
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of diltiazem on hepatic drug metabolizing enzymes in man using antipyrine, trimethadione and debrisoquine as model substrates.
    Sakai H; Kobayashi S; Hamada K; Iida S; Akita H; Tanaka E; Uchida E; Yasuhara H
    Br J Clin Pharmacol; 1991 Mar; 31(3):353-5. PubMed ID: 2054276
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The warfarin-sulfinpyrazone interaction: stereochemical considerations.
    Toon S; Low LK; Gibaldi M; Trager WF; O'Reilly RA; Motley CH; Goulart DA
    Clin Pharmacol Ther; 1986 Jan; 39(1):15-24. PubMed ID: 3943265
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impairment of drug metabolism in polycystic non-parasitic liver disease.
    Sotaniemi EA; Luoma PV; Järvensivu PM; Sotaniemi KA
    Br J Clin Pharmacol; 1979 Oct; 8(4):331-5. PubMed ID: 508507
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A link between liver microsomal enzyme activity and thyroid hormone metabolism in man.
    Ohnhaus EE; Studer H
    Br J Clin Pharmacol; 1983 Jan; 15(1):71-6. PubMed ID: 6849748
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immediate decrease by hydrocortisone of the plasma half-life of antipyrine.
    Breckenridge A; Burke CW; Davies DS; Orme ML
    Br J Pharmacol; 1973 Feb; 47(2):434-6. PubMed ID: 4722054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.